{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T02:46:53Z","timestamp":1779245213489,"version":"3.51.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,2,14]],"date-time":"2014-02-14T00:00:00Z","timestamp":1392336000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1007\/s00403-014-1451-0","type":"journal-article","created":{"date-parts":[[2014,2,13]],"date-time":"2014-02-13T05:23:01Z","timestamp":1392268981000},"page":"505-509","source":"Crossref","is-referenced-by-count":12,"title":["Topical non-peptide antagonists of sensory neurotransmitters substance P and CGRP do not modify patch test and prick test reactions: a vehicle-controlled, double-blind pilot study"],"prefix":"10.1007","volume":"306","author":[{"given":"Joanna","family":"Wallengren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Edvinsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,2,14]]},"reference":[{"key":"1451_CR1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0378-4274(95)03393-Y","volume":"80","author":"ED Barber","year":"1995","unstructured":"Barber ED, Hill T, Schum DB (1995) The percutaneous absorption of hydroquinone (HQ) through rat and human skin in vitro. Toxicol Lett 80:167\u2013172","journal-title":"Toxicol Lett"},{"key":"1451_CR2","first-page":"665","volume":"164","author":"N Booken","year":"2011","unstructured":"Booken N, Heck M, Nicolay JP, Klemke CD, Goerdt S, Utikal J (2011) Oral aprepitant in the therapy of refractory pruritus in erythrodermic cutaneous T-cell lymphoma. Br J Dermatol 164:665\u2013667","journal-title":"Br J Dermatol"},{"key":"1451_CR3","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1056\/NEJMc0906670","volume":"361","author":"A Duval","year":"2009","unstructured":"Duval A, Dubertret L (2009) Aprepitant as an antipruritic agent? N Engl J Med 361:1415\u20131416","journal-title":"N Engl J Med"},{"key":"1451_CR4","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0140-6736(10)60323-6","volume":"376","author":"L Edvinsson","year":"2010","unstructured":"Edvinsson L, Linde (2010) M.New drugs in migraine treatment and prophylaxis: telcagepant and topiramate. Lancet 376:645\u2013655","journal-title":"Lancet"},{"key":"1451_CR5","unstructured":"European Medicines Agency. Pharmaceutical quality system (ICH Q10) (2011) Available at: http:\/\/www.cdc.gov\/niosh\/topics\/skin\/skinPermCalc.html"},{"key":"1451_CR6","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/0272-4332.00024","volume":"22","author":"HF Frasch","year":"2002","unstructured":"Frasch HF (2002) A random walk model of skin permeation. Risk Anal 22:265\u2013276","journal-title":"Risk Anal"},{"key":"1451_CR7","first-page":"53","volume-title":"Manual of contact dermatitis","author":"S Fregert","year":"1974","unstructured":"Fregert S (1974) Patch testing. In: Fregert S (ed) Manual of contact dermatitis. Munksgaard, Copenhagen, p 53"},{"key":"1451_CR8","first-page":"1","volume":"192","author":"M Lod\u00e9n","year":"1995","unstructured":"Lod\u00e9n M (1995) Biophysical properties of dry atopic and normal skin with special reference to effects of skin care products. Acta Derm Venereol Suppl 192:1\u201348","journal-title":"Acta Derm Venereol Suppl"},{"key":"1451_CR9","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1023\/A:1015810312465","volume":"9","author":"RO Potts","year":"1992","unstructured":"Potts RO, Guy RH (1992) Predicting skin permeability. Pharm Res 9:663\u2013669","journal-title":"Pharm Res"},{"issue":"5","key":"1451_CR10","doi-asserted-by":"crossref","first-page":"497","DOI":"10.2340\/00015555-1265","volume":"92","author":"A Reich","year":"2012","unstructured":"Reich A, Heisig M, Phan NQ, Taneda K, Takamori K, Takeuchi S, Furue M, Blome C, Augustin M, St\u00e4nder S, Szepietowski J (2012) Visual Analogue Scale: Evaluation of the Instrument for the Assessment of Pruritus. Acta Derm Venereol 92(5):497\u2013501","journal-title":"Acta Derm Venereol"},{"key":"1451_CR11","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.biomaterials.2011.11.011","volume":"33","author":"PP Shah","year":"2012","unstructured":"Shah PP, Desai PR, Patel AR, Singh MS (2012) Skin permeating nanogel for the cutaneous co-delivery of two anti-inflammatory drugs. Biomaterials 33:1607\u20131617","journal-title":"Biomaterials"},{"issue":"1","key":"1451_CR12","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ejpb.2010.05.009","volume":"76","author":"Y Shono","year":"2010","unstructured":"Shono Y, Jantratid E, Kesisoglou F, Reppas C, Dressman JB (2010) Forecasting in vivo oral absorption and food effect of micronized and nanosized aprepitant formulations in humans. Eur J Pharm Biopharm 76(1):95\u2013104","journal-title":"Eur J Pharm Biopharm"},{"issue":"6","key":"1451_CR13","doi-asserted-by":"crossref","first-page":"e10968","DOI":"10.1371\/journal.pone.0010968","volume":"5","author":"S St\u00e4nder","year":"2010","unstructured":"St\u00e4nder S, Siepmann D, Herrgott I, Sunderk\u00f6tter C, Luger TA (2010) Targeting the neurokinin receptor 1 with aprepitant: a novel antipruritic strategy. PLoS ONE 5(6):e10968. doi: 10.1371\/journal.pone.0010968","journal-title":"PLoS ONE"},{"key":"1451_CR14","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1365-2133.1991.tb00591.x","volume":"124","author":"J Wallengren","year":"1991","unstructured":"Wallengren J (1991) Substance P antagonist inhibits immediate and delayed type cutaneous hypersensitivity reactions. Br J Dermatol 124:324\u2013328","journal-title":"Br J Dermatol"},{"key":"1451_CR15","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1358\/dnp.1999.12.7.863641","volume":"12","author":"J Wallengren","year":"1999","unstructured":"Wallengren J (1999) Neuropeptides: Their significance in the skin. Drug News & Perspectives 12:401\u2013411","journal-title":"Drug News & Perspectives"},{"key":"1451_CR16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1034\/j.1600-0536.2000.043003137.x","volume":"43","author":"J Wallengren","year":"2000","unstructured":"Wallengren J (2000) Dual effects of CGRP-antagonist on allergic contact dermatitis in human skin. Contact Dermatitis 43:137\u2013143","journal-title":"Contact Dermatitis"},{"issue":"8","key":"1451_CR17","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1001\/archdermatol.2012.1018","volume":"148","author":"J Wallengren","year":"2012","unstructured":"Wallengren J (2012) Topical aprepitant does not attenuate clinical or experimental pruritus. Arch Dermatol 148(8):957\u2013959","journal-title":"Arch Dermatol"},{"issue":"4","key":"1451_CR18","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1529-8019.2005.00041.x","volume":"18","author":"J Wallengren","year":"2005","unstructured":"Wallengren J (2005) Neuroanatomy and neurophysiology of itch. Dermatol Ther 18(4):292\u2013303","journal-title":"Dermatol Ther"},{"issue":"7","key":"1451_CR19","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/0045-6535(95)00023-2","volume":"30","author":"A Wilschut","year":"1995","unstructured":"Wilschut A, ten Berge WF, Robinson PJ, McKone TE (1995) Estimating skin permeation. The validation of five mathematical skin permeation models. Chemosphere 30(7):1275\u20131296","journal-title":"Chemosphere"},{"key":"1451_CR20","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1093\/ndt\/gfm375","volume":"22","author":"G Yosipovitch","year":"2007","unstructured":"Yosipovitch G, Duque MI, Patel TS, Ishiuji Y, Guzman-Sanchez DA, Dawn AG, Freedman BI, Chan YH, Crumrine D, Elias PM (2007) Skin barrier structure and function and their relationship to pruritus in end-stage renal disease. Nephrol Dial Transplant 22:3268\u20133279","journal-title":"Nephrol Dial Transplant"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-014-1451-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00403-014-1451-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-014-1451-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T13:39:55Z","timestamp":1559050795000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00403-014-1451-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,14]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["1451"],"URL":"https:\/\/doi.org\/10.1007\/s00403-014-1451-0","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,14]]}}}